DEFA14A: Orchestra BioMed Holdings Sets Date for 2024 Annual Meeting, Outlines Voting Matters
Proxy Statement
Orchestra BioMed Holdings, Inc. will hold its annual meeting on June 20, 2024, and is soliciting votes on the election of directors and ratification of its accounting firm.
Summary
- Orchestra BioMed Holdings, Inc. is holding its 2024 Annual Meeting on June 20, 2024.
- Stockholders are being asked to vote on the election of two Class I directors: Eric A. Rose, M.D. and Jason Aryeh.
- A proposal to ratify the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, is also on the ballot.
- The proxy materials, including the Notice, Proxy Statement, and Form 10-K, are available online.
- Stockholders can request a free paper or email copy of the materials before June 6, 2024.
- Votes must be cast by June 19, 2024, at 11:59 PM Eastern Time.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, indicating a neutral sentiment. It reflects routine corporate governance activities.
Positives
- Stockholders have multiple options for accessing proxy materials and voting, including online, phone, and email.
- The company provides clear instructions and deadlines for voting.
Future Outlook
The document outlines the matters to be voted on at the upcoming annual meeting, providing a glimpse into the company's governance and operational focus for the coming year.
Industry Context
This is a standard proxy filing related to an upcoming annual meeting, a routine part of corporate governance for publicly traded companies.
Stakeholder Impact
- Shareholders are asked to participate in corporate governance by voting on key proposals.
- The outcome of the votes will influence the composition of the board of directors and the selection of the company's auditor.
Next Steps
- Stockholders should review the proxy materials and vote on the proposals.
- The company will hold its Annual Meeting on June 20, 2024.
Key Dates
| Date | Description |
|---|---|
| June 6, 2024 | Deadline to request a free paper or email copy of proxy materials. |
| June 19, 2024 | Deadline to vote (11:59 PM Eastern Time). |
| June 20, 2024 | 2024 Annual Meeting (11:00 a.m. Eastern Time). |
| December 31, 2024 | End of fiscal year for which Ernst & Young LLP is being considered as the independent registered public accounting firm. |
Keywords
Annual Meeting, Proxy Statement, Stockholders, Voting, Directors, Ernst & Young, Orchestra BioMed
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.